233 related articles for article (PubMed ID: 29724507)
21. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
22. Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.
Lewis ER; David VR; Doyle AL; Rajabi K; Kiefer JA; Pirrotte P; Barker BM
Eukaryot Cell; 2015 Oct; 14(10):1043-53. PubMed ID: 26275879
[TBL] [Abstract][Full Text] [Related]
23. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
[TBL] [Abstract][Full Text] [Related]
24. Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides.
Gonzalez A; Hung CY; Cole GT
Microb Pathog; 2011 Dec; 51(6):432-41. PubMed ID: 21896326
[TBL] [Abstract][Full Text] [Related]
25. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
26. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
27. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
28. Development of vaccines for coccidioidomycosis.
Levine HB; Pappagianis D; Cobb JM
Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
[No Abstract] [Full Text] [Related]
29. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
30. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
31. Dectin-1 is required for resistance to coccidioidomycosis in mice.
Viriyakosol S; Jimenez Mdel P; Gurney MA; Ashbaugh ME; Fierer J
mBio; 2013 Feb; 4(1):e00597-12. PubMed ID: 23386437
[TBL] [Abstract][Full Text] [Related]
32. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
[TBL] [Abstract][Full Text] [Related]
33. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
34. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
[TBL] [Abstract][Full Text] [Related]
35. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
36. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
37. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
[TBL] [Abstract][Full Text] [Related]
38. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Walch HA; Kalvoda A
Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
[No Abstract] [Full Text] [Related]
39. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
40. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
